产品标题 产品货号 产品规格 厂家
Tetratricopeptide repeat domain 39C (TTC39C), transcript variant 1 from ORIGENE TECHNOLOGIESLY427747100 ugORIGENE TECHNOLOGIES
Tetratricopeptide repeat domain 39C (TTC39C), transcript variant 2 from ORIGENE TECHNOLOGIESLY407140100 ugORIGENE TECHNOLOGIES
Tetratricopeptide repeat domain 23-like (TTC23L) from ORIGENE TECHNOLOGIESLY408153100 ugORIGENE TECHNOLOGIES
Tetratricopeptide repeat domain 1 (TTC1) from ORIGENE TECHNOLOGIESLY418776100 ugORIGENE TECHNOLOGIES
Tetratricopeptide repeat domain 12 (TTC12) from ORIGENE TECHNOLOGIESLY413490100 ugORIGENE TECHNOLOGIES
Tetratricopeptide repeat domain 16 (TTC16) from ORIGENE TECHNOLOGIESLY408103100 ugORIGENE TECHNOLOGIES
Tetratricopeptide repeat domain 17 (TTC17) from ORIGENE TECHNOLOGIESLY413197100 ugORIGENE TECHNOLOGIES
Tetratricopeptide repeat domain 18 (TTC18) from ORIGENE TECHNOLOGIESLY408032100 ugORIGENE TECHNOLOGIES
Tetratricopeptide repeat domain 19 (TTC19) from ORIGENE TECHNOLOGIESLY413548100 ugORIGENE TECHNOLOGIES
Tetratricopeptide repeat domain 24 (TTC24) from ORIGENE TECHNOLOGIESLY426295100 ugORIGENE TECHNOLOGIES
Tetratricopeptide repeat domain 25 (TTC25) from ORIGENE TECHNOLOGIESLY410532100 ugORIGENE TECHNOLOGIES
Tetratricopeptide repeat domain 27 (TTC27) from ORIGENE TECHNOLOGIESLY413586100 ugORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS8009925x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS8043385x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS5014185x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS5014195x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS5014225x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS5397415x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6010065x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6010075x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6157115x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6157125x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6157915x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6157925x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6166145x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6175975x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6196565x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6200875x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6204425x5umORIGENE TECHNOLOGIES
Human Uterus and adnexa; Adenocarcinoma of endometrium or ovary, endometrioid from ORIGENE TECHNOLOGIESCS7038585x5umORIGENE TECHNOLOGIES
Human Uterus and adnexa; Adenocarcinoma of endometrium or ovary, endometrioid from ORIGENE TECHNOLOGIESCS7038595x5umORIGENE TECHNOLOGIES
Human Uterus; Carcinosarcoma of endometrium from ORIGENE TECHNOLOGIESCS8049535x5umORIGENE TECHNOLOGIES
Human Uterus; Carcinosarcoma of endometrium from ORIGENE TECHNOLOGIESCS8049555x5umORIGENE TECHNOLOGIES
Human Uterus; Carcinosarcoma of endometrium from ORIGENE TECHNOLOGIESCS8049565x5umORIGENE TECHNOLOGIES
Human Uterus; Carcinosarcoma of endometrium from ORIGENE TECHNOLOGIESCS8049585x5umORIGENE TECHNOLOGIES
Human Uterus; Carcinosarcoma of endometrium from ORIGENE TECHNOLOGIESCS8049595x5umORIGENE TECHNOLOGIES
Human Uterus; Carcinosarcoma of endometrium from ORIGENE TECHNOLOGIESCS8056545x5umORIGENE TECHNOLOGIES
Human Uterus; Carcinosarcoma of endometrium from ORIGENE TECHNOLOGIESCS8049615x5umORIGENE TECHNOLOGIES
Human Uterus; Carcinosarcoma of endometrium from ORIGENE TECHNOLOGIESCS8056555x5umORIGENE TECHNOLOGIES
Human Uterus; Carcinosarcoma of endometrium from ORIGENE TECHNOLOGIESCS6208665x5umORIGENE TECHNOLOGIES
Human Uterus; Carcinosarcoma of endometrium from ORIGENE TECHNOLOGIESCS6183335x5umORIGENE TECHNOLOGIES
Human Uterus; Endometritis from ORIGENE TECHNOLOGIESCS8045065x5umORIGENE TECHNOLOGIES
Human Uterus; Endometrium, atrophic from ORIGENE TECHNOLOGIESCS6021935x5umORIGENE TECHNOLOGIES
Human Uterus; Endometrium, disordered proliferative from ORIGENE TECHNOLOGIESCS6374255x5umORIGENE TECHNOLOGIES
Human Uterus; Endometrium, proliferative from ORIGENE TECHNOLOGIESCS7129345x5umORIGENE TECHNOLOGIES
Human Uterus; Endometrium, proliferative from ORIGENE TECHNOLOGIESCS5009315x5umORIGENE TECHNOLOGIES
Human Uterus; Endometrium, proliferative from ORIGENE TECHNOLOGIESCS5042265x5umORIGENE TECHNOLOGIES
Human Uterus; Endometrium, proliferative from ORIGENE TECHNOLOGIESCS5043185x5umORIGENE TECHNOLOGIES
Human Uterus; Endometrium, proliferative from ORIGENE TECHNOLOGIESCS5046555x5umORIGENE TECHNOLOGIES
Human Uterus; Endometrium, proliferative from ORIGENE TECHNOLOGIESCS5074505x5umORIGENE TECHNOLOGIES
 |< < 2566 2567 2568 2569 2570 2571 2572 2573 2574 > >| 第 2572/6274 页